ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/05/2023
Back to search
Official data from USPTO
CONNECTING MOLECULES TO MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONNECTING MOLECULES TO MEDICINE
ST13
US500000090201288Class
5
Filing
90201288
Registration
6734284
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/05/2023
Trademark type
Word
Nice classes
5
Filing date
09/22/2020
Registration date
05/24/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/24/2022
Last transaction
05/24/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/02/2018
First use in commerce
12/02/2018
Drawing code
4
Owner type
16
Owner location
LINCOLNSHIRE, IL, US
Examiner
DWYER, JOHN D
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NEXUS PHARMACEUTICALS II, LLC
Nexus Pharmaceuticals, Inc.
Representatives
Randy Micheletti INCUBATE IP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of metabolic disorders; Pharmaceutical preparations for the treatment of endocrine disorders; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of blood pressure disorders; Pharmaceutical preparations for the treatment of blood clotting disorders; Pharmaceutical preparations for the treatment of cancer-related conditions; Pharmaceutical preparations for the treatment of psychotic diagnoses; Pharmaceutical preparations for the treatment of gastrointestinal conditions
Publications
History of USPTO decisions and trademark events.
23 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/08/2022
PUBO
PUBLISHED FOR OPPOSITION
03/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/16/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/29/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2022
ALIE
ASSIGNED TO LIE
01/25/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/20/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/16/2021
GNSL
LETTER OF SUSPENSION E-MAILED
08/16/2021
CNSL
SUSPENSION LETTER WRITTEN
08/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/13/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2021
GNRT
NON-FINAL ACTION E-MAILED
02/13/2021
CNRT
NON-FINAL ACTION WRITTEN
02/13/2021
DOCK
ASSIGNED TO EXAMINER
02/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/30/2020
NWAP
NEW APPLICATION ENTERED
09/25/2020
Continuous trademark protection
Get notified about every new filing that threatens CONNECTING MOLECULES TO MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.